New onset of depression in aging women and men: contributions of social, psychological, behavioral, and somatic predictors in the community.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 23 8 2018
medline: 25 4 2020
entrez: 23 8 2018
Statut: ppublish

Résumé

Based on the vulnerability-stress model, we aimed to (1) determine new onset of depression in individuals who had not shown evidence of depression at baseline (5 years earlier) and (2) identify social, psychological, behavioral, and somatic predictors. Longitudinal data of N = 10 036 participants (40-79 years) were evaluated who had no evidence of depression at baseline based on Patient Health Questionnaire (PHQ-9), no history of depression, or intake of antidepressants. Multivariate logistic regression models were used to predict the onset of depression. Prevalence of new cases of depression was 4.4%. Higher rates of women (5.1%) than men (3.8%) were due to their excess incidence <60 years of age. Regression analyses revealed significant social, psychological, behavioral, and somatic predictors: loneliness [odds ratio (OR) 2.01; 95% confidence interval (CI) 1.48-2.71], generalized anxiety (OR 2.65; 1.79-3.85), social phobia (OR 1.87; 1.34-2.57), panic (OR 1.67; 1.01-2.64), type D personality (OR 1.85; 1.47-2.32), smoking (OR 1.35; 1.05-1.71), and comorbid cancer (OR 1.58; 1.09-2.24). Protective factors were age (OR 0.88; 0.83-0.93) and social support (OR 0.93; 0.90-0.95). Stratified by sex, cancer was predictive for women; for men smoking and life events. Entered additionally, the PHQ-9 baseline score was strongly predictive (OR 1.40; 1.34-1.47), generalized anxiety became only marginally, and panic was no longer predictive. Other predictors remained significant, albeit weaker. Psychobiological vulnerability, stress, and illness-related factors were predictive of new onset of depression, whereas social support was protective. Baseline subclinical depression was an additional risk weakening the relationship between anxiety and depression by taking their overlap into account. Vulnerability factors differed between men and women.

Sections du résumé

BACKGROUND
Based on the vulnerability-stress model, we aimed to (1) determine new onset of depression in individuals who had not shown evidence of depression at baseline (5 years earlier) and (2) identify social, psychological, behavioral, and somatic predictors.
METHODS
Longitudinal data of N = 10 036 participants (40-79 years) were evaluated who had no evidence of depression at baseline based on Patient Health Questionnaire (PHQ-9), no history of depression, or intake of antidepressants. Multivariate logistic regression models were used to predict the onset of depression.
RESULTS
Prevalence of new cases of depression was 4.4%. Higher rates of women (5.1%) than men (3.8%) were due to their excess incidence <60 years of age. Regression analyses revealed significant social, psychological, behavioral, and somatic predictors: loneliness [odds ratio (OR) 2.01; 95% confidence interval (CI) 1.48-2.71], generalized anxiety (OR 2.65; 1.79-3.85), social phobia (OR 1.87; 1.34-2.57), panic (OR 1.67; 1.01-2.64), type D personality (OR 1.85; 1.47-2.32), smoking (OR 1.35; 1.05-1.71), and comorbid cancer (OR 1.58; 1.09-2.24). Protective factors were age (OR 0.88; 0.83-0.93) and social support (OR 0.93; 0.90-0.95). Stratified by sex, cancer was predictive for women; for men smoking and life events. Entered additionally, the PHQ-9 baseline score was strongly predictive (OR 1.40; 1.34-1.47), generalized anxiety became only marginally, and panic was no longer predictive. Other predictors remained significant, albeit weaker.
CONCLUSIONS
Psychobiological vulnerability, stress, and illness-related factors were predictive of new onset of depression, whereas social support was protective. Baseline subclinical depression was an additional risk weakening the relationship between anxiety and depression by taking their overlap into account. Vulnerability factors differed between men and women.

Identifiants

pubmed: 30131081
pii: S0033291718001848
doi: 10.1017/S0033291718001848
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1148-1155

Commentaires et corrections

Type : ErratumIn

Auteurs

Manfred E Beutel (ME)

Department of Psychosomatic Medicine and Psychotherapy,University Medical Center of the Johannes Gutenberg-University Mainz,Germany.

Elmar Brähler (E)

Department of Psychosomatic Medicine and Psychotherapy,University Medical Center of the Johannes Gutenberg-University Mainz,Germany.

Joerg Wiltink (J)

Department of Psychosomatic Medicine and Psychotherapy,University Medical Center of the Johannes Gutenberg-University Mainz,Germany.

Jasmin Ghaemi Kerahrodi (JG)

Department of Psychosomatic Medicine and Psychotherapy,University Medical Center of the Johannes Gutenberg-University Mainz,Germany.

Juliane Burghardt (J)

Department of Psychosomatic Medicine and Psychotherapy,University Medical Center of the Johannes Gutenberg-University Mainz,Germany.

Matthias Michal (M)

Department of Psychosomatic Medicine and Psychotherapy,University Medical Center of the Johannes Gutenberg-University Mainz,Germany.

Andreas Schulz (A)

Preventive Cardiology and Preventive Medicine, Center for Cardiology,University Medical Center of the Johannes Gutenberg-University Mainz,Germany.

Phillipp S Wild (PS)

Preventive Cardiology and Preventive Medicine, Center for Cardiology,University Medical Center of the Johannes Gutenberg-University Mainz,Germany.

Thomas Münzel (T)

Center for Translational Vascular Biology (CTVB),University Medical Center of the Johannes Gutenberg-University Mainz,Germany.

Irene Schmidtmann (I)

Institute for Medical Biostatistics, Epidemiology and Informatics,University Medical Center Mainz,Germany.

Karl J Lackner (KJ)

Institute of Clinical Chemistry and Laboratory Medicine,University Medical Center of the Johannes Gutenberg-University Mainz,Germany.

Norbert Pfeiffer (N)

Department of Ophthalmology,University Medical Center of the Johannes Gutenberg-University Mainz,Germany.

Andreas Borta (A)

Boehringer Ingelheim Pharma GmbH Co KG,Ingelheim am Rhein,Germany.

Ana N Tibubos (AN)

Department of Psychosomatic Medicine and Psychotherapy,University Medical Center of the Johannes Gutenberg-University Mainz,Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH